Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-11-27
Target enrollment:
Participant gender:
Summary
The ratios of the geometric means of the ODT formulation to those of the reference
formulation (conventional tablet) for the bioavailability variables (Cmax, AUCt, and AUC∞ of
brexpiprazole (OPC-34712)).